Topic: Hepatitis
The first clinical trials on a new investigational drug being developed to treat infections caused by Hepatitis C virus have been successfully completed. Completion of the initial phase (phase 1a) of ... moreThe first clinical trials on a new investigational drug being developed to treat infections caused by Hepatitis C virus have been successfully completed. Completion of the initial phase (phase 1a) o ... more
The first clinical trials on a new investigational drug being developed to treat infections caused by hepatitis C virus have been successfully completed. Completion of the initial phase (phase 1a) of ... more
ldquo;[Researchers] quantified antibody responses to the hepatitis C virus (HCV) proteome that are associated with sustained virologic response (SVR) in human immunodeficiency virus (HIV)/HCV-coinfec ... more
A simple intervention helps people with severe mental illness overcome the barriers to preventive services for blood-borne infections such as HIV and hepatitis B and C virus. Medscape Medical News ... more
September issue highlights, including discussion of a possible association between hepatitis B infection and non-Hodgkin lymphoma in a Korean population. ... more
The 2 agencies recommend other precautions for fingerstick devices, glucometers, and insulin pens to curb the spread of bloodborne pathogens such as hepatitis B. Medscape Medical News ... more
Aethlon Medical, Inc. (OTC Bulletin Board: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced that the Medanta Independent Ethics Comm ... more
Concerned that many of its drugmakers may be taken over in a wave of mergers and acquisitions, the Indian government is being urged to consider compulsory licensing to assure that prices - particularl ... more
Updated Date: Aug 25, 2010 EST ... more
Updated Date: Aug 25, 2010 EST ... more
Updated Date: Aug 25, 2010 EST ... more
Overweight Volunteers Ulcerative Colitis Hepatitis C /div ... more
A recombinant vaccine prevents hepatitis E virus infection in healthy adults, according to new study from China. Medscape Medical News ... more
An experimental vaccine appears to be safe and effective in protecting people against hepatitis E infection, a large trial in China has found.Source: Reuters Health Related MedlinePlus Pages: Hepatiti ... more
Ongoing research suggests it's a potent form of protection against infection ... more
Adding a direct acting anti-viral drug to the standard treatment regimen for hepatitis C significantly increases the cure rate in the most difficult to treat patients, according to a research report p ... more
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced results from the Phase 3 ILLUMINATE study, which was designed to evaluate whether there was any benefit to extending therapy from 24 to 48 ... more
A new generation of antiviral drugs can help reverse liver fibrosis and even early cirrhosis in patients with chronic hepatitis B virus infection, and they continue to work for many years, new researc ... more
Researchers have found that patients with chronic hepatitis B virus (HBV) infection who received at least 3 years of cumulative entecavir (antiviral) therapy achieved substantial histologic improvemen ... more
Not all viruses are created equal. In liver transplant patients with chronic hepatitis C virus (HCV) infection, only viruses that can dodge the immune response invade the new liver, according to a stu ... more
The Donor Risk Index, which assesses donor characteristics impacting liver transplantation outcomes, does not bear the same impact on outcomes on a small scale as is suggested from large-scale, nation ... more
NICE is currently updating part of its guidance on the use of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C. Reflecting changes in the licensed indications for peginterfero ... more
The National Institute for Health and Clinical Excellence (NICE) has issued a final appraisal determination (FAD) on the use of peginterferon alfa and ribavirin for the treatment of chronic hepatitis ... more
Pharmasset, Inc. (Nasdaq: VRUS) has received fast track designation from the U.S. Food and Drug Administration (FDA) for PSI-7977 for the treatment of chronic hepatitis C virus (HCV) infection. PSI-7 ... more
Viral hepatitis B and C contribute to "the death[s] of 15,000 Americans a year" and threaten "the health of 5.3 million more," Sen. John Kerry (D-Mass.) and Rep. Michael Honda (D-Calif.) write in a Wa ... more
Hepatitis B virus, like hepatitis C, is associated with a significant increase in risk for non-Hodgkin's lymphoma. Medscape Medical News ... more
Adding the NS3 protease inhibitor boceprevir to standard treatment with pegylated interferon and ribavirin for hepatitis C infection can double the sustained response rate vs standard treatment alone. ... more
Good morning, everyone. Another balmy day on the Pharmalot corporate campus, where we are doing our best to keep cool. We trust you are doing the same. Meanwhile, deadlines and meetings continue to lo ... more
Study shows promise, but experts say questions remain, including issues of viral resistance Source: HealthDay Related MedlinePlus Page: Hepatitis C ... more
Multiple Sclerosis Hepatitis C Systemic Lupus Erythematosus (SLE) /div ... more
Late-stage clinical trials find that adding Merck's boceprevir to standard hepatitis C therapy increases the viral cure rate up to 75% -- efficacy similar to that of Vertex's telaprevir. ... more
For the first time in three years, Merck can now say that all of its pediatric vaccines are again available. The disclosure, which was made on its supply status web page on Aug. 2, follows a series of ... more
Study shows promise, but experts say questions remain, including issues of viral resistance ... more
Youth, prison inmates and individuals with multiple tattoos that cover large parts of their bodies are at higher risk of contracting hepatitis C and other blood-borne diseases, according to a Universi ... more
Adding a direct acting anti-viral drug to the standard treatment regimen for hepatitis C significantly increases the cure rate in the most difficult to treat patients, according to a research report p ... more
INDIANAPOLIS — Adding a direct acting anti-viral drug to the standard treatment regimen for hepatitis C significantly increases the cure rate in the most difficult to treat patients, according to a r ... more
Women with HIV have higher rates of adverse events from treatment for hepatitis C virus (HCV) compared to men with HIV, researchers reported online July 8th in the Journal of Acquired Immune Deficienc ... more
Adding a direct acting anti-viral drug to the standard treatment regimen for hepatitis C significantly increases the cure rate in the most difficult to treat patients, according to a new study. ... more
Youth, prison inmates and individuals with multiple tattoos that cover large parts of their bodies are at higher risk of contracting hepatitis C and other blood-borne diseases, according to a new stud ... more
Merck reported that two pivotal Phase III registration studies for boceprevir, its investigational oral hepatitis C protease inhibitor, have been completed and met the primary endpoints: in both studi ... more
Legislation introduced today by Senator John Kerry, "The Viral Hepatitis and Liver Cancer Control and Prevention Act," would transform our nation's approach to identifying and treating chronic viral h ... more
Information from the Unlinked Anonymous Monitoring Survey of HIV and Viral Hepatitis among Injecting Drug Users is presented from 1990 to 2009. This survey looks at infectious diseases in a sample of ... more
Good morning, all. Nice to you see on what looks to be a sunny day here on the Pharmalot corporate campus. The summer haze may have arrived, but we remain as busy as ever. So please join as we quaff o ... more
Earlier today, Merck touted clinical trial results for its becoprevir hepatitis C treatment, but a quick read of the data is not good news for the big drugmaker. Why? The outcome was good, but everyth ... more
People infected with hepatitis B virus are around twice as likely to develop non-Hodgkin lymphoma, researchers reported on Tuesday.Source: Reuters Health Related MedlinePlus Pages: Hepatitis B, Lympho ... more
Updated Date: Aug 4, 2010 EST ... more
ENGERIX-B (Hepatitis B Vaccine (Recombinant)) Injection, Suspension [GlaxoSmithKline Biologicals SA]
Study finds twice the risk of non-Hodgkin lymphoma ... more
Scientists have made an important discovery that could lead to new drugs that reduce the severity of blood infections leading to sepsis. Research presented in the August 2010 issue of Journal of Leuko ... more
Updated Date: Aug 2, 2010 EST ... more
Updated Date: Aug 2, 2010 EST ... more
The aim of cancer immunotherapy is the stimulation of immune mechanisms to recognize malignant cells and may be a useful complementary therapy to conventional anticancer therapy. Immunotherapy was ini ... more
New research published in the Journal of Leukocyte Biology suggests that blocking a membrane protein called Programmed Death 1 improves survival in a clinically relevant model of severe infection Sci ... more
Pancreatic ductal adenocarcinoma (the disease commonly referred to as pancreatic cancer) carries the worst prognosis of any cancer. As current treatments offer minimal benefit, entirely new approaches ... more
Vanishing bile duct syndrome (VBDS) refers to a group of disorders characterized by destruction and disappearance of intrahepatic (inside the liver) bile ducts. Multiple causes have been identified in ... more
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, particularly in China. However, HCC remains one of the more difficult cancers to treat. It is important to screen for new an ... more
Updated Date: Jul 30, 2010 EST ... more
In early 2009, Merck disclosed that manufacturing issues would disrupt supplies of its Recombivax hepatitis B vaccine for adults. Supplies of other vaccines have also been constrained. For instance, o ... more
Forwarded by a friend of his, and I have the authors #8217; express permission to run it. Hey Gang, Another amazing and emotional day yesterday. I try to write about things that impress me professiona ... more
Iron Deficiency Anemia Hepatitis C Rheumatoid Arthritis /div ... more
A laboratory study suggests that silymarin #8212;an extract from the milk thistle plant #8212;has multiple effects against the lifecycle of the hepatitis C virus. Hepatitis C is a chronic (long lastin ... more
A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV the ... more
ldquo;A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti- ... more
Researchers have observed that depressive symptoms in patients with hepatitis C virus (HCV) infection are commonly overlooked in routine clinical interviews, and that treatment-induced depression comp ... more
This fact sheet provides basic information about the herb astragalus #8212;common names, uses, potential side effects, and resources for more information. Native to China, astragalus has been used for ... more
A team of biochemists has identified the molecular mechanism by which an immune response is triggered by the invading viruses, according to recent research. The results could eventually lead to new th ... more
Efforts to raise disease awareness in the Philippines have increased the number of cases and patient pool available for hepatitis C treatment. Screening and detection efforts by the Red Cross as well ... more
Microfluidic device uses antibodies to #8216;capture #8217; white blood cells called T cells affected by HIV UC Davis biomedical engineer Prof. Alexander Revzin has developed a #8220;lab on a chip # ... more
A universal influenza vaccine—so-called because it could potentially provide protection from all flu strains for decades—may become a reality because of research led by scientists from the National ... more
An immune-system protein already used to treat diseases like multiple sclerosis, hepatitis C and a variety of cancers might also aid asthma patients, researchers have found. ... more
To prevent infections transmitted by acupuncture, infection control measures should be implemented, such as use of disposable needles, skin disinfection procedures and aseptic techniques.Acupuncture m ... more
An immune-system protein already used to treat diseases like multiple sclerosis, hepatitis C and a variety of cancers might also aid asthma patients, researchers have found. ... more
The FDA has approved an expanded indication for interferon alfacon-1 subcutaneous injection, in combination with ribavirin, for retreatment of chronic hepatitis C viral infection. Medscape Medical N ... more
Diagnosis of celiac disease is based on a characteristic enteropathy in an intestinal biopsy and evidence that these changes are gluten-triggered. The appropriate use of simpler and more accurate tool ... more
A watchdog group has asked the Federal Trade Commission to investigate contract pricing arrangements that Merck and Sanofi-Pasteur offer physician practices. In a letter to the FTC, the Citizens for R ... more
A year ago, we reported on the push to discover an effective AIDS vaccine. As President Obama prepares to release his U.S. AIDS strategy, at least one pharmaceutical company is readying a crucial clin ... more
The U.S. Food and Drug Administration announced approval of the first rapid blood test for antibodies to the hepatitis C virus (HCV) for individuals 15 years and older. The OraQuick HCV Rapid Antibo ... more
U.S. urges vaccination for children 12-23 months Source: HealthDay Related MedlinePlus Pages: Childhood Immunization, Hepatitis A ... more
July 1, 2010 #8212; Viral hepatitis affects more than 500 million people worldwide and is a cause of liver failure and liver cancer. While vaccines are available for hepatitis A and B, this is not th ... more
Viral hepatitis affects more than 500 million people worldwide and while vaccines are available for hepatitis A and B, this is not the case for hepatitis C, which affects as much as two percent of the ... more
U.S. urges vaccination for children 12-23 months ... more
Reports that at least 18,000 veterans from Missouri, Illinois and some other states may have been exposed to Hepatitis B, Hepatitis C and HIV blood-borne pathogens at the John Cochran VA Medical Cente ... more
Small study finds antiviral therapy halts recurrence in patients with chronic hepatitis B Source: HealthDay Related MedlinePlus Pages: Hepatitis B, Liver Cancer ... more
Small study finds antiviral therapy halts recurrence in patients with chronic hepatitis B ... more
European legislation that requires all couples undergoing assisted reproduction treatment (ART) to be screened for HIV and hepatitis at the time of every sperm or egg donation is unnecessary, expensiv ... more
The FDA has approved the first rapid blood test for antibodies to the hepatitis C virus in patients aged 15 years and older who are at risk for HCV or have signs/symptoms of hepatitis. Medscape Medi ... more
Source: Food and Drug Administration Related MedlinePlus Page: Hepatitis C ... more
In the wake of several hepatitis outbreaks, a JAMA study found frequent lapses in infection management. ... more
The U.S. Food and Drug Administration announced approval of the first rapid blood test for antibodies to the hepatitis C virus (HCV) for individuals 15 years and older. The OraQuick HCV Rapid Antibody ... more
Nonalcoholic steatohepatitis (NASH) is manifestation of metabolic syndrome in the liver and is a pandemic over the globe especially in the developed countries, based on a high calorie diet and sedenta ... more
Nonalcoholic steatohepatitis (NASH) is manifestation of metabolic syndrome in the liver and is a pandemic over the globe especially in the developed countries, based on a high calorie diet and sedenta ... more
The U.S. Food and Drug Administration today announced approval of the first rapid blood test for antibodies to the hepatitis C virus (HCV) for individuals 15 years and older. ... more
The U.S. Food and Drug Administration today announced approval of the first rapid blood test for antibodies to the hepatitis C virus (HCV) for individuals 15 years and older. ... more
Previous studies have shown that antiviral treatment reduces the incidence of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). But now, researchers from the Division of Gastr ... more
Professor Massimo Palmarini will lead the new Medical Research Council - University of Glasgow Centre for Virus Research. Scientists working in the Centre will tackle questions about both human and an ... more
Previous studies have shown that antiviral treatment reduces the incidence of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B. But now, researchers are reporting that the antiviral ... more
In HIV patients being treated with ribavirin for hepatitis C, mitochondrial toxicity might actually be a good sign. It's associated with higher rates of sustained virologic response, say researchers f ... more
A new provisional clinical opinion issued by the American Society of Clinical Oncology came out against routine screening, but one institution has already implanted such a protocol. Medscape Medical ... more
C-reactive protein (CRP) is used to assess disease activity in diverse inflammatory disorders including inflammatory bowel disease (IBD). However, in IBD, a significant number of patients present with ... more
(PHILADELPHIA) Previous studies have shown that antiviral treatment reduces the incidence of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). But now, researchers from the Di ... more
Colorectal cancer, cancer of the colon and rectum, is a common cause of mortality worldwide. Statistical data showed that the number of deaths caused by colorectal cancer is increasing in both men and ... more
Ulcerative colitis (UC) is characterized by frequent diarrheal attacks and anal bleeding. Histologic characteristics of UC are the invasion of the crypt epithelium and lamina propria by peripheral blo ... more
In HIV patients being treated with ribavirin for hepatitis C, mitochondrial toxicity might actually be a good sign. It's associated with higher rates of sustained virologic response, say researchers f ... more
Rome, Italy, Saturday 19 June 2010: For healthcare professionals diagnosing primary Sjögren #8217;s Syndrome (pSS, an autoimmune disorder in which immune cells attack and destroy moisture-producing g ... more
Diarrhea represents a major condition responsible for pediatric mortality worldwide. The onset of neonatal diarrhea may rapidly lead to life threatening dehydration and malnutrition. Clinical and epid ... more
The pathogenesis of chronic hepatitis C (CHC) is associated with severe oxidative stress and non-selective immunological disturbance that lead to necroinflammation and the progression of fibrosis. Sev ... more
A research team from Cuba investigated the efficacy of Viusid, a nutritional supplement, as an antioxidant and an immunomodulator in patients with chronic hepatitis C. Their results showed that treatm ... more
Recent research, funded in part by NCCAM and published in the journal Gastroenterology, has shown that an extract of the milk thistle plant may help treat hepatitis C virus infection. Hepatitis C, a l ... more
Researchers hope to identify patients for whom treatment will be ineffective Source: HealthDay Related MedlinePlus Pages: Genes and Gene Therapy, Hepatitis C ... more
A small genetic change can predict how people infected with hepatitis C react to treatment, paving the way to personalised therapy for this difficult to treat disease, the annual conference of the Eur ... more
A small genetic change can predict how people infected with hepatitis C react to treatment, paving the way to personalized therapy for this difficult-to-treat disease. ... more
Contact: Mary Rice mary@mrcommunication.org European Society of Human Genetics May spare side effects to those in whom treatment would be ineffective Gothenburg, Sweden: A small genetic change can pre ... more
Researchers hope to identify patients for whom treatment will be ineffective ... more
Drugs used for obesity, diabetes might fight dangerous liver infection, study shows ... more
A review offers recommendations for diagnosis and treatment of hepatitis C in the family practice setting. Medscape Medical News ... more
Contact: Dawn Peters healthnews@wiley.com 781-388-8408 Wiley-Blackwell Adverse events increase when ligation is combined with nadolol A controlled trial conducted by researchers at the E-DA Hospital i ... more
Common drugs used to treat conditions such as diabetes and obesity could be used to successfully treat hepatitis C virus infection. Research led by the University of Leeds has found drugs such as anti ... more
Common drugs used to treat conditions such as diabetes and obesity could be used to successfully treat hepatitis C virus infection. Research led by the University of Leeds has found drugs such as anti ... more
Common drugs used to treat conditions such as diabetes and obesity could be used to successfully treat hepatitis C virus infection. Research led by the University of Leeds has found drugs such as anti ... more
Comprehensive study shows earlier treatment leads to numerous and significant individual and societal benefits compared with 2006 guidelines Vancouver, British Columbia (June 7, 2010) – Researchers f ... more
Common drugs used to treat conditions such as diabetes and obesity could be used to successfully treat hepatitis C virus infection. ... more
ZymoGenetics, Inc. (NASDAQ:ZGEN) today announced the initiation of the second part of a Phase 2 clinical trial with PEG-Interferon lambda (IL-29) and ribavirin in treatment-naïve patients with chro ... more
In a high-risk urban population, a significant proportion of patients were tested for HCV; the prevalence of HCV infection was high. Medscape Medical News ... more
Vertex Pharmaceuticals has released promising Phase III data for its experimental hepatitis C drug telaprevir, positioning the drug candidate for potential blockbuster status. The New York Times repor ... more
Researchers have made a significant new discovery about RNA (ribonucleic acid) viruses and how they replicate themselves. Certain RNA viruses -- poliovirus, hepatitis C virus and coxsackievirus -- and ... more
Researchers found that antiviral therapy during compensated cirrhosis, when compared with all other strategies, is the most cost-effective approach to treating patients with advanced liver disease due ... more
6 grants awarded to design ways to outsmart, outlast disease-causing bugs 1. Singapore's Agency for Science, Technology and Research (A*STAR) and the UK's Medical Research Council (MRC) have announced ... more
Adding the experimental hepatitis C drug telaprevir to standard interferon/ribavirin therapy cured 75% of newly treated patients and shortened treatment time, drug maker Vertex announced. ... more
Hepatitis C is one of the hottest areas for drug development and Vertex Pharmaceuticals has released a study that gives new hope to patients and investors. The results show its Telaprevir treatment in ... more
NICE is currently updating part of its guidance on the use of peginterferon alfa and ribavirin for the treatment of chronic hepatitis C. Reflecting changes in the licensed indications for peginterfero ... more
A study conducted by researchers at the Cleveland Clinic finds that patients suffering from cirrhosis preceded by nonalcoholic steatohepatitis are at an equal risk of developing hepatocellular carcino ... more
As we brush our teeth, take our long showers, and drink our eight glasses a day, it #8217;s easy to forget that nearly one billion people in the world don #8217;t have access to clean water. Poor sani ... more
Contact: Dawn Peters medicalnews@wiley.com 781-388-8408 Wiley-Blackwell NASH-induced cirrhosis rivals HCV in development of hepatocellular carcinoma A study conducted by researchers at the Cleveland C ... more
A new study finds that patients suffering from cirrhosis preceded by nonalcoholic steatohepatitis are at an equal risk of developing hepatocellular carcinoma than those who develop cirrhosis resulting ... more
Hepatitis C Type 2 Diabetes Gout /div ... more
AIDSinfo announces the release of the updated Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmissio ... more
May is Hepatitis Awareness Month,1 and you may find it surprising to learn an estimated 4 million Americans have been infected with Hepatitis C. This silent disease is three to five times more prevale ... more
ldquo;HIV-1 natural viral suppressors (NVSs) demonstrate an intrinsic ability to control HIV-1 replication in the absence of antiretroviral therapy. The objective of this study was to investigate whe ... more
Contact: Ye-Ru Wang wjg@wjgnet.com 86-105-908-0039 World Journal of Gastroenterology Dietary factors have long been known to play a major role in the development of obesity. The global increasing prev ... more
Honoring Hepatitis Awareness Month in May and marking World Hepatitis Awareness Day on May 19 are critical ways to raise awareness and understanding about the global burden of viral hepatitis. ... more
Dr. Ming-Heng Wu of the Institute of Basic Medical Sciences at National Cheng Kung University (NCKU), Taiwan, in collaboration with Prof. Chawnshang Chang's laboratory of University of Rochester (UR), ... more
Dr. Ming-Heng Wu of the Institute of Basic Medical Sciences at National Cheng Kung University (NCKU), Taiwan, in collaboration with Prof. Chawnshang Chang's laboratory of University of Rochester (UR), ... more
A University of Rochester study helps to explain why men get liver cancer more often than women and opens the door for a new treatment pathway, by showing a direct link between the androgen receptor, ... more
A University of Rochester study helps to explain why men get liver cancer more often than women and opens the door for a new treatment pathway, by showing a direct link between the androgen receptor, ... more
Contact: Leslie Orr Leslie_Orr@urmc.rochester.edu 585-275-5774 University of Rochester Medical Center A University of Rochester study helps to explain why men get liver cancer more often than women an ... more
A new study helps to explain why men get liver cancer more often than women and opens the door for a new treatment pathway, by showing a direct link between the androgen receptor, which is more active ... more
An inexpensive new test for the detection of Hepatitis B virus has been given regulatory approval for use in the European Union. The test, developed with support from the Wellcome Trust, delivers accu ... more
Treatment to reduce recurrence of hepatitis B appears to improve liver transplant outcomes for some patients, according to a new study. ... more
New figures released by the Health Protection Agency (HPA) show reported cases of Hepatitis C infection in England to have increased by 4.5% from 8,196 cases reported in 2008 to 8,563 cases in 2009. ... more
MitoSciences announces that it has just been awarded $590,000 by the National Institutes of Health to support the development of companion diagnostic tests for antiviral drugs. The award was made afte ... more
The first clinical trials have started on a new investigational drug which is being developed to treat infections caused by hepatitis C virus. ... more
Recent studies have demonstrated that type 2 diabetes mellitus (DM) is associated with high risk of hepatocellular carcinoma (HCC) development in patients with chronic hepatitis C. Insulin resistance ... more
Recent studies have demonstrated that type 2 diabetes mellitus (DM) is associated with high risk of hepatocellular carcinoma (HCC) development in patients with chronic hepatitis C. Insulin resistance ... more
Contact: Lin Tian wjg@wjgnet.com 86-105-908-0039 World Journal of Gastroenterology Duodenocaval fistula (DCF) is an uncommon but lethal clinical entity. The high mortality has been attributed to the d ... more
Contact: Lin Tian wjg@wjgnet.com 86-105-908-0039 World Journal of Gastroenterology Hepatocellular carcinoma (HCC) responds poorly to chemotherapy owing to MDR. Recent studies have shown the tumors der ... more
Contact: Lin Tian wjg@wjgnet.com 86-105-908-0039 World Journal of Gastroenterology Numerous studies have documented the favorable effects of MARS albumin dialysis treatment on clinical and laboratory ... more
Contact: Lin Tian wjg@wjgnet.com 86-105-908-0039 World Journal of Gastroenterology Probiotics are a group of live microorganisms administered in adequate amounts which confer a beneficial health effec ... more
Hepatitis C Prostate Cancer Related Pain Pediatric Migraine /div ... more
Contact: Ye-Ru Wang wjg@wjgnet.com 86-105-908-0039 World Journal of Gastroenterology Gastric cancer is the most common malignant gastrointestinal cancer and accounts for 25% of cancer deaths. Nuclear ... more
Contact: Ye-Ru Wang wjg@wjgnet.com 86-105-908-0039 World Journal of Gastroenterology Eradication of Helicobacter pylori (H. pylori) is a well-accepted initial therapy in cases of localized (stage … E ... more
Contact: Ye-Ru Wang wjg@wjgnet.com 86-105-908-0039 World Journal of Gastroenterology Colorectal cancer (CRC) is one of the major causes of cancer death in the developed countries. Accumulated evidence ... more
Teva Parenteral Medicine and Baxter Healthcare Services were ordered to pay more than $5 million after a jury found the companies liable in the first civil trial stemming from Southern Nevada #8217;s ... more
Most cases could be prevented, but improvements in viral hepatitis services are needed to reverse this trend, according to the Center for Diseases Control and Prevention. Medscape Medical News ... more
More people need to be vaccinated, diagnosed and treated, CDC report says Source: HealthDay Related MedlinePlus Pages: Hepatitis, Liver Cancer ... more
Dynavax Technologies Corporation (NASDAQ: DVAX) reported completing the first immunizations of over 2,000 subjects enrolled in its large-scale Phase 3 study of HEPLISAV „¢. This starts a 12-month foll ... more
Contact: Ye-Ru Wang wjg@wjgnet.com 86-105-908-0039 World Journal of Gastroenterology Hepatocellular carcinoma (HCC) is an aggressive tumor with poor long-term prognosis. The reported 5-year recurrence ... more
Hello, everyone. Nice to see you again. A busy day lies ahead and so, as you have come to expect, we are brewing the required cup of stimulation to jumpstart the process. Perhaps you wish to do the sa ... more
In patients with refractory genotype 1 hepatitis C virus (HCV), adding telaprevir to peg-interferon and ribavirin significantly increases rapid and sustained viral response rates, researchers announce ... more
A prescription drug already approved to treat genital warts and skin cancer may have a new use in boosting the effectiveness of future vaccines for bacterial and viral diseases, such as hepatitis C an ... more
A combination of antiviral drugs may be needed to combat the drug resistance that rapidly develops in potentially deadly hepatitis C infections, a new study using sophisticated computer and mathematic ... more
Contact: Sherri McGinnis González smcginn@uic.edu 312-996-8277 University of Illinois at Chicago A combination of antiviral drugs may be needed to combat the drug resistance that rapidly develops in ... more
Extending hepatitis C treatment for liver transplant patients beyond current standards results in high clearance rates of the hepatitis C virus from the blood, and a low relapse rate, according to a n ... more
A prescription drug already approved to treat genital warts and skin cancer may have a new use in boosting the effectiveness of future vaccines for bacterial and viral diseases, such as hepatitis C an ... more
A combination of antiviral drugs may be needed to combat the drug resistance that rapidly develops in potentially deadly hepatitis C infections, a new study using sophisticated computer and mathematic ... more
Gout Knee Pain (Arthritis) Hepatitis B Vaccine /div ... more
Research presented at Digestive Disease Week® (DDW®) shows that using telaprevir in the treatment regimen for hepatitis C virus (HCV) is highly effective, particularly in difficult-to-treat cases. F ... more
Contact: Michael Bernstein m_bernstein@acs.org 202-872-6042 American Chemical Society A prescription drug already approved to treat genital warts and skin cancer may have a new use in boosting the eff ... more
Contact: Jennifer Hirsch jfhirsch@mit.edu 617-253-1682 Massachusetts Institute of Technology Findings may have implications for designing effective AIDS vaccine CAMBRIDGE, Mass. #8212; When people be ... more
The Australian Nursing Federation is gravely concerned about the serious risk to nurses from needlestick injury, with more than 18,000 pricked by syringes and sharps each year. Ged Kearney, ANF Feder ... more
Patients with chronic diseases require a high level of care to manage their conditions. They may undergo regular injections or infusion therapies that require careful compliance, or they may need help ... more
Undiagnosed and untreated pediatric hepatitis C is a grave concern, antibiotic use in the first year of life triples the risk of inflammatory bowel disease (IBD), drugs used to treat IBD in pregnant w ... more
Contact: Amy Levey alevey@gymr.com 202-745-5116 Digestive Disease Week Health outcomes explored at DDW 2010 NEW ORLEANS, LA (May 3, 2010) – High protein intake may be associated with increased risk ... more
Undiagnosed and untreated pediatric hepatitis C is a grave concern, antibiotic use in the first year of life triples the risk of inflammatory bowel disease (IBD), drugs used to treat IBD in pregnant w ... more
Untreated, the infection can lead to liver damage, liver cancer, researcher says Source: HealthDay Related MedlinePlus Pages: Children's Health, Hepatitis C ... more
Contact: Amy Levey alevey@gymr.com 202-745-5116 Digestive Disease Week Health outcomes explored at DDW 2010 NEW ORLEANS, LA (May 2, 2010) – Non-alcoholic fatty liver disease (NAFLD), which may soon ... more
Untreated, the infection can lead to liver damage, liver cancer, researcher says ... more
Contact: Maria Seyrig mseyrig1@hfhs.org 313-874-4039 Henry Ford Health System DETROIT – Extending hepatitis C treatment for liver transplant patients beyond current standards results in high clearanc ... more
Osteopontin serum levels are 5 times higher in patients with alcoholic hepatitis than in control subjects, suggesting a new avenue of treatment for this population. Medscape Medical News ... more
Although hepatitis and alcohol-related disease have the highest odds ratios as risk factors for liver cancer, more cases are attributable to diabetes. Medscape Medical News ... more
Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the Data Safety Monitoring Board (DSMB) established for Dynavax's two ongoing Phase 3 trials for HEPLISAV „¢ has assessed subject s ... more
Simultaneous anti-HIV therapy with antiretroviral drugs and tuberculosis (TB) prophylaxis with isoniazid does not make isoniazid-associated hepatitis any more likely, according to a report published o ... more
Only 7% of nonresponders with hepatitis C virus (HCV) genotype 1 infection had a sustained virologic response with nitazoxanide plus standard therapy, according to newly released data. Medscape Medi ... more
One third of patients undergoing liver transplantation as a result of hepatitis C virus (HCV) infection showed a sustained virologic response (SVR) afterward. Medscape Medical News ... more
24 weeks of treatment could be sufficient to cure between 93 and 100% of treatment-na iuml;ve chronic hepatitis C virus (HCV) genotype 1 (G1) infected patients if they have a fast antiviral respons ... more
Chronic Obstructive Pulmonary Disease (COPD) Hepatitis B Vaccine Gout /div ... more
Results from two French studies presented at the International Liver CongressTM 2010 press conference will help inform clinical practice in the treatment of patients with severe or acute ... more
An experimental Bristol-Myers Squibb compound called BMS-790052 is proving to be the most potent yet at treating hepatitis C, company researchers said on Wednesday. Reuters Health Information ... more
Medication offers hope for treatment with fewer side effects, experts say ... more
An experimental oral drug is showing early promise for the treatment of chronic hepatitis C virus (HCV) infection, a study shows. ... more
Gilead Sciences, Inc. (Nasdaq:GILD) today announced the company is stopping its ongoing Phase II clinical trial of GS 9450, an investigational caspase inhibitor, in patients with chronic hepatitis C. ... more